New on YCharts: We've added nearly 10,000 securities to our database with coverage of OTCMARKETS HIDE

Dendreon (DNDN)

Create an Alert
4.09 +0.04  +0.99%   NASDAQ Jun 17, 5:00PM BATS Real time Currency in USD

Dendreon R&D Expense Quarterly:

18.45M for March 31, 2013
View Full Chart

Dendreon R&D Expense Quarterly Chart

    Dendreon Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 18.45M
    Dec. 31, 2012 18.96M
    Sept. 30, 2012 18.64M
    June 30, 2012 19.70M
    March 31, 2012 17.34M
    Dec. 31, 2011 17.70M
    Sept. 30, 2011 20.42M
    June 30, 2011 18.56M
    March 31, 2011 17.61M
    Dec. 31, 2010 12.24M
    Sept. 30, 2010 13.54M
    June 30, 2010 20.74M
    March 31, 2010 29.41M
    Dec. 31, 2009 19.97M
    Sept. 30, 2009 16.49M
    June 30, 2009 13.32M
    March 31, 2009 11.80M
    Dec. 31, 2008 10.76M
    Sept. 30, 2008 12.66M
    June 30, 2008 13.19M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    DNDN R&D Expense Quarterly Benchmarks

    Companies
    Medivation 22.00M
    Sarepta Therapeutics 13.76M
    Spectrum Pharmaceuticals 11.98M

    DNDN R&D Expense Quarterly Rankings

    Overall 96th percentile
    576 of 16773
    Sector 89th percentile
    145 of 1408 in Healthcare
    Industry 89th percentile
    49 of 453 in Biotechnology

    DNDN R&D Expense Quarterly Range, Past 5 Years

    Minimum 10.76M Dec 2008
    Maximum 29.41M Mar 2010
    Average 17.08M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');